Development of orally bioavailable bicyclic pyrazolones as inhibitors of tumor necrosis factor-α production

被引：138

作者：

Clark, MP ^{[1
]}

Laughlin, SK ^{[1
]}

Laufersweiler, MJ ^{[1
]}

Bookland, RG ^{[1
]}

Brugel, TA ^{[1
]}

Golebiowski, A ^{[1
]}

Sabat, MP ^{[1
]}

Townes, JA ^{[1
]}

VanRens, JC ^{[1
]}

Djung, JF ^{[1
]}

Natchus, MG ^{[1
]}

De, B ^{[1
]}

Hsieh, LC ^{[1
]}

Xu, SC ^{[1
]}

Walter, RL ^{[1
]}

Mekel, MJ ^{[1
]}

Heitmeyer, SA ^{[1
]}

Brown, KK ^{[1
]}

Juergens, K ^{[1
]}

Taiwo, YO ^{[1
]}

Janusz, MJ ^{[1
]}

机构：

[1] Procter & Gamble Pharmaceut, Mason, OH 45040 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2004年 / 47卷 / 11期

关键词：

D O I：

10.1021/jm049968m

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

2-Aryl-3-pyrimidinyl based tumor necrosis factor-alpha (TNF-alpha) inhibitors, which contain a novel bicyclic pyrazolope core, are described. Many showed low-nanomolar activity against lipopolysaccharide-induced TNF-alpha production in monocytic cells. Secondary screening data are presented for the pyrimidinyl bicyclic pyrazolones. Several of these analogues showed good oral bioavailability in rat and efficacy in the rat iodoacetate in vivo model.

引用

页码：2724 / 2727

页数：4

共 50 条

[41] Fullerenes and their derivatives as inhibitors of tumor necrosis factor-α with highly promoted affinities
Wu, Gaoyin
Gao, Xuejiao J.
Jang, Joonkyung
Gao, Xingfa
JOURNAL OF MOLECULAR MODELING, 2016, 22 (07)
[42] Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor-α Inhibitors
Bradford, Russell D.
Pettit, April C.
Wright, Patty W.
Mulligan, Mark J.
Moreland, Larry W.
McLain, David A.
Gnann, John W.
Bloch, Karen C.
CLINICAL INFECTIOUS DISEASES, 2009, 49 (06) : 924 - 927
[43] Tumor necrosis factor-α inhibitors and preeclampsia: assessing the evidence for risk reduction
Tang, Wei-Zhen
Xu, Wei-Ze
Liu, Tai-Hang
JOURNAL OF HYPERTENSION, 2025, 43 (01) : 181 - 182
[44] Safety and Tolerability of Tumor Necrosis Factor-α Inhibitors in Psoriasis: A Narrative Review
Ashley L. Semble
Scott A. Davis
Steven R. Feldman
American Journal of Clinical Dermatology, 2014, 15 : 37 - 43
[45] Synthesis and structure-activity relationship of cyclopentenone mdmes as novel inhibitors of the production of tumor necrosis factor-α
Kim, Yeonjoon
Hong, Yong Deog
Joo, Yung Hyup
Woo, Byung Young
Kim, Sun-Young
Koh, Hyun Ju
Park, Miyoung
Byoun, Kyoung Hee
Shin, Song Seok
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (13) : 2807 - 2810
[46] Myocardial expression of tumor necrosis factor-α and tumor necrosis factor-α converting enzyme in human myocarditis
Satoh, M
Nakamura, M
Satoh, H
Segawa, I
Masuda, T
Hiramori, K
CIRCULATION, 1999, 100 (18) : 381 - 381
[47] Effects of tumor necrosis factor-α inhibitors on lung lesions with rheumatoid arthritis
Inoue, KI
Takano, H
Yanagisawa, R
Yoshikawa, T
CHEST, 2003, 124 (01) : 413 - 414
[48] Frequency of Thrombocytopenia in Psoriasis Patients Treated With Tumor Necrosis Factor-α Inhibitors
Chen, Meng
Holland, Michael J.
Mir, Mohsin R.
Wong, Michael G.
Kelley, Brian P.
Grim, Kelli D.
Bhuchar, Sunaina S.
Hsu, Sylvia
JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (03) : 280 - 284
[49] Fullerenes and their derivatives as inhibitors of tumor necrosis factor-α with highly promoted affinities
Gaoyin Wu
Xuejiao J. Gao
Joonkyung Jang
Xingfa Gao
Journal of Molecular Modeling, 2016, 22
[50] The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-α or isoproterenol
Takahashi, N.
Yoshizaki, T.
Hiranaka, N.
Kumano, O.
Suzuki, T.
Akanuma, M.
Yui, T.
Kanazawa, K.
Yoshida, M.
Naito, S.
Fujiya, M.
Kohgo, Y.
Ieko, M.
INTERNATIONAL JOURNAL OF OBESITY, 2015, 39 (05) : 747 - 754

← 1 2 3 4 5 →